Announcements Trials

Browse Landscape

Phase

Phase 2 58 Phase 3 20 Phase 1 16 Phase 1/2 8 Phase 2/3 3 Phase NA 1 Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 5 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Thromboembolism 1 Stomach Neoplasms 1 Non-small Cell Lung Cancer Metastatic 1 Extensive Stage Small Cell Lung Cancer (ES-SCLC) 1 Breast Neoplasms 1

Interventions

Exercise 112 Surveys and Questionnaires 55 Early Intervention, Educational 49 Standard of Care 46 Methods 46 Magnetic Resonance Spectroscopy 45 Blood Specimen Collection 44 Acupuncture Therapy 44 Educational Status 43 Radiotherapy 36 Mammography 36 Control Groups 31 Therapeutics 29 Counseling 29 Psychiatric Rehabilitation 27 Cyclophosphamide 27 Sentinel Lymph Node Biopsy 25 Biopsy 24 Yoga 20 Mastectomy, Segmental 20 Resistance Training 19 Palliative Care 18 Neoadjuvant Therapy 18 High-Energy Shock Waves 18 Doxorubicin 18 Cognitive Behavioral Therapy 18 Magnetic Resonance Imaging 17 Practice Guidelines as Topic 16 Paclitaxel 16 Trastuzumab 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Breast Neoplasms × 130-nm albumin-bound paclitaxel × Clear all

NCT02064829 2016-03-25

TRIBECA

Sorrento Therapeutics, Inc.

Phase NA Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡